Cysteinyl leukotrienes induce nasal symptoms of allergic rhinitis via a receptor-mediated mechanism in guinea pigs

Japanese Journal of Pharmacology

Volumn 75, Issue 4, 1997, Pages 355-362

  Fujita, Manabu ^a   Nakagawa, Naoki ^a   Yonetomi, Yasuo ^a   Takeda, Hiroshi ^a   Kawabata, Kazuhito ^a   Ohno, Hiroyuki ^a  

^a ONO PHARMACEUTICAL CO   (Japan)

Author keywords

Cysteinyl leukotriene; Eosinophil; Pranlukast; Receptor; Rhinitis

Indexed keywords

EPINASTINE; LEUKOTRIENE C4; LEUKOTRIENE D4; LEUKOTRIENE D4 RECEPTOR; LEUKOTRIENE E4; PEPTIDOLEUKOTRIENE; PRANLUKAST; RECEPTOR;

ALLERGIC RHINITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING AFFINITY; BINDING SITE; CONTROLLED STUDY; DISSOCIATION CONSTANT; EOSINOPHIL; GUINEA PIG; MALE; NONHUMAN; NOSE AIRWAY RESISTANCE; NOSE MUCOSA; NOSE SECRETION; ORAL DRUG ADMINISTRATION; RADIORECEPTOR ASSAY; SNEEZING;

EID: 0031447142     PISSN: 00215198     EISSN: None     Source Type: Journal    
DOI: 10.1254/jjp.75.355     Document Type: Article

References (21)

1. Holtzman MJ: Arachidonic acid metabolism. Am Rev Respir Dis 143, 188-203 (1991)
2. Hay DWP, Torphy TJ and Undem BJ: Cysteinyl leukotrienes in asthma: old mediators up to new tricks. Trends Pharmacol Sci 16, 304-308 (1995)
3. Naclerio RM, Baroody FM and Togias AG: The role of leukotrienes in allergic rhinitis: a review. Am Res Respir Dis 143, 591-595 (1991)
4. 4 in allergic rhinitis. Ann Allergy 60, 537-540 (1988)
5. Pipkorn U, Proud D, Lichtenstein LM, Schleimer RP, Peters SP, Adkinson NF Jr, Kagey-Sobotka A, Norman PS and Naclerio RM: Effect of short-term systemic glucocorticoid treatment on human nasal mediator release after antigen challenge. J Clin Invest 80, 957-961 (1987)
6. Obata T, Okada Y, Motoishi M, Nakagawa N, Terawaki T and Aishita H: In vitro antagonism of ONO-1078, a newly developed anti-asthma agent, against peptide leukotrienes in isolated guinea pig tissues. Jpn J Pharmacol 60, 227-237 (1992)
7. Nakagawa N, Obata T, Kobayashi T, Okada Y, Nambu F, Terawaki T and Aishita H: In vivo pharmacologic profile of ONO-1078: A potent, selective and orally active peptide leukotrienene (LT) antagonist. Jpn J Pharmacol 60, 217-225 (1992)
8. Pennock BE, Cox CP, Rogers RM, Cain WA and Wells JH: A noninvasive technique for measurement of changes in specific airway resistance. J Appl Physiol 46, 399-406 (1979)
9. Narita S and Asakura K: The effects of anti-PAF and other agents on the nasal symptoms in sensitized guinea pigs. Auris Nasus Larynx 20, 175-183 (1993)
10. 4 in the guinea pig lung. Biochem Biophys Res Commun 116, 1136-1143 (1983)
11. Augstein J, Farmer JB, Lee TB, Sheard P and Tattersall ML: Selective inhibitor of slow reacting substance of anaphylaxis. Nature (New Biol) 245, 215-217 (1973)
12. 4 receptors. J Pharmacol Exp Ther 248, 581-588 (1989)
13. Drazen JM and Austen KF: Leukotrienes and airway responses. Am Rev Respir Dis 136, 985-998 (1987)
14. 4 in humans. Am Rev Respir Dis 131, 368-372 (1985)
15. Foster A and Chan CC: Peptide leukotriene involvement in pulmonary eosinophil migration upon antigen challenge in the actively sensitized guinea pig. Int Arch Allergy Appl Immunol 96, 279-284 (1991)
16. 4 administration in the guinea pig. Am Respir Crit Care Med 154, 850-857 (1996)
17. 4 effects on human eosinophil and neutrophil motility in vitro. J Leukocyte Biol 55, 183-191 (1994)
18. 4. Mol Pharmacol 32, 223-229 (1987)
19. 2 receptor antagonist (Bay u 3405) on nasal symptoms after antigen challenge in sensitized guinea pigs. Int Arch Allergy Immunol 109, 161-166 (1996)
20. Knani J, Campbell A, Enander I, Peterson CGB, Michel F-B and Bousquet J: Indirect evidencce of nasal inflammation assessed by titration of inflammatory mediators and enumeration of cells in nasal secretions of petients with chronic rhinitis. J Allergy Clin Immunol 90, 880-889 (1992)
21. Jörg A, Henderson WR, Murphy RC and Klebanoff SJ: Leukotriene generation by eosinophils. J Exp Med 155, 390-402 (1982)